Cargando…

Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway.

BACKGROUND: Progression of Benign Prostate hyperplasia (BPH) is vulnerable to oxidative stress (OS) and prostatic enlargement among the aging males through apoptosis deregulation. Our present study aimed to investigate the effect of neferine (NF) in the regulation of oxidative stress and apoptosis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahan, Nabila, Chowdhury, Apu, Li, Ting, Xu, Ke, Wei, Fen, Wang, Sicen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808392/ https://www.ncbi.nlm.nih.gov/pubmed/33416009 http://dx.doi.org/10.1080/13510002.2021.1871814

Ejemplares similares

One month of the novel coronavirus 2019 outbreak: Is it still a threat?
por: Chowdhury, Apu, et al.
Publicado: (2020)

Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways
por: Liu, Chi-Ming, et al.
Publicado: (2023)

Neferine treatment enhances the TRAIL-induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway
por: Nazim, Uddin Md, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Oxidative stress biomarkers in dogs with benign prostatic hyperplasia
por: Domoslawska, Anna, et al.
Publicado: (2022)

Neferine induces apoptosis by modulating the ROS-mediated JNK pathway in esophageal squamous cell carcinoma
por: An, Kang, et al.
Publicado: (2020)

A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status
por: Chowdhury, Apu, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia
por: D’Amico, Ramona, et al.
Publicado: (2021)

Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
por: Jin, Bo-Ram, et al.
Publicado: (2020)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet
por: Li, Yongzhi, et al.
Publicado: (2019)

Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis
por: Hsu, Chao Yu, et al.
Publicado: (2021)

Liensinine and neferine exert neuroprotective effects via the autophagy pathway in transgenic Caenorhabditis elegans
por: Wu, Meng-chen, et al.
Publicado: (2023)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Neferine induces p38 MAPK/JNK1/2 activation to modulate melanoma proliferation, apoptosis, and oxidative stress
por: Xie, Jun, et al.
Publicado: (2020)

Origanum majorana L. Extract Attenuated Benign Prostatic Hyperplasia in Rat Model: Effect on Oxidative Stress, Apoptosis, and Proliferation
por: Elsherbini, Dalia Mahmoud Abdelmonem, et al.
Publicado: (2022)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

Fibronectin Pattern in Benign Hyperplasia and Cancer of the Prostate
por: Janković, Miroslava M., et al.
Publicado: (2008)

Metabolic syndrome and benign prostatic hyperplasia: An update
por: Ngai, Ho-Yin, et al.
Publicado: (2017)

Genetic alterations in benign prostatic hyperplasia patients
por: Mohamed, Hanaa Mahmoud, et al.
Publicado: (2017)

Commentary on “Solving the benign prostatic hyperplasia puzzle”
por: Thomas, Dominique, et al.
Publicado: (2018)

Recent advances in prostatectomy for benign prostatic hyperplasia
por: Te, Alexis E.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qkio35r8gl6bbvtd1bb6d38f36